Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,338 | 4,357 | 881 | 1,195 | 2,815 |
| Marketable Securities | N/A | 500 | 4,721 | 6,414 | 7,611 |
| TOTAL | $2,557 | $4,986 | $6,168 | $8,188 | $10,980 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 102 | 111 | 119 | 127 | 24 |
| TOTAL | $2,141 | $2,150 | $2,158 | $2,166 | $2,063 |
| Total Assets | $4,698 | $7,136 | $8,326 | $10,354 | $13,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,737 | 663 | 907 | 690 | 1,268 |
| TOTAL | $1,772 | $697 | $940 | $721 | $1,291 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 78 | 87 | 96 | 0 |
| TOTAL | $69 | $78 | $87 | $96 | $N/A |
| Total Liabilities | $1,841 | $775 | $1,027 | $817 | $1,291 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 182 | 179 | 179 | 179 | 179 |
| Common Shares | 1 | 3 | 3 | 3 | 3 |
| Retained earnings | -50,136 | -46,358 | -45,226 | -42,793 | -40,310 |
| Other shareholders' equity | -202 | -218 | -203 | -203 | -203 |
| TOTAL | $2,857 | $6,361 | $7,299 | $9,537 | $11,752 |
| Total Liabilities And Equity | $4,698 | $7,136 | $8,326 | $10,354 | $13,043 |